Mutations in Kit Confer Imatinib Resistance in Gastrointestinal Stromal Tumors

• 1. 一种用于检测伊马替尼和/或N-去甲基伊马替尼的检测试剂和检测试剂盒 [P] . 中国专利： CN112946282A . 2021-06-11
• 2. 一种用于检测伊马替尼靶向用药相关基因突变的试剂盒 [P] . 中国专利： CN110964824A . 2020-04-07
• 3. Mutations in KIT confer imatinib resistance in gastrointestinal stromal tumors [P] . 美国专利： US7329495B2 . 2008-02-12

  机译： KIT突变赋予胃肠道间质瘤伊马替尼耐药

• 4. Mutations in KIT confer imatinib resistance in gastrointestinal stromal tumors [P] . 美国专利： US2006019280A1 . 2006-01-26

  机译： KIT突变赋予胃肠道间质瘤伊马替尼耐药

• 5. MEDICINAL COMPOSITION FOR TREATING GASTROINTESTINAL STROMAL TUMOR (GIST) AND KIT AND METHOD FOR ESTIMATING THE PROGNOSIS OF PATIENT SUFFERING FROM GASTROINTESTINAL STROMAL TUMOR [P] . 世界知识产权组织专利： WO2009069680A1 . 2009-06-04

  机译： 治疗胃肠道间质瘤（gist）的药物组合物和估计胃肠道间质瘤患者预后的方法

• 1. Mutation of the KIT Gene, excluding Exon 11, in Gastrointestinal Stromal Tumors [J] . LIU Qiu Yu, KONG Ling Fei, XU Zi Gung, 生物医学与环境科学（英文版） . 2020,第005期
• 2. International classifications of gastrointestinal stromal tumor: a clue for adjuvant imatinib treatment [C] . Tzen Chin-Yuan International Gastric Cancer Congress . 2011
• 3. Molecular mechanisms of response in gastrointestinal stromal tumors treated with imatinib mesylate [D] . McAuliffe, John Christopher 2007
• 4. KRAS and KIT Gatekeeper Mutations Confer Polyclonal Primary Imatinib Resistance in GI Stromal Tumors: Relevance of Concomitant Phosphatidylinositol 3-Kinase/AKT Dysregulation [O] . César Serrano, Yuexiang Wang, Adrián Mariño-Enríquez, -1
• 5. Activating mutations in c-KIT and PDGFRα are exclusively found in gastrointestinal stromal tumors and not in other tumors overexpressing these imatinib mesylate target genes [O] . Kk Burger, Michael A. den Bakker, Johan M. Kros, 2005

• 1. Imatinib response of gastrointestinal stromal tumor patients with germline mutation on KIT exon 13:A family report [J] . Gulgun Engin ,Serpil Eraslan ,Hülya Kayserili . 世界放射学杂志：英文版（电子版） . 2017,第9期
• 2. KIT exon 11 codon 557/558 deletion/insertion mutations define a subset of gastrointestinal stromal tumors with malignant potential [J] . Katerina Kontogianni-Katsarou ,Euthimios Dimitriadis ,Constantina Lariou . 世界胃肠病学杂志：英文版 . 2008,第12期
• 3. Sporadic somatic mutation of c-kit gene in a family with gastrointestinal stromal tumors without cutaneous hyperpigmentation [J] . Chun-Nan Yeh ,Tsung-Wen Chen . 世界胃肠病学杂志：英文版 . 2006,第11期
• 4. Prognostic value of KIT mutation in gastrointestinal stromal tumors [J] . Xiao-HongLiu ,Chen-GuangBai ,QiangXie . 世界胃肠病学杂志：英文版 . 2005,第25期
• 5. 胃肠道间质瘤伊马替尼继发性耐药机制的研究和靶向治疗的新选择 [C] . 郑松 ,潘月龙 ,郑晓亮 . 2013抗肿瘤药物研究新进展与肿瘤个性化药物治疗论坛 . 2013
• 6. 伊马替尼治疗胃肠道间质瘤的临床疗效和安全分析 [A] . 杨怀玺 . 2021